FABP1 and metabolic dysfunction-associated steatotic liver disease: FABP1 has been shown to be elevated in several metabolic diseases, such as MASLD, obesity, and diabetes [48,53,54], suggesting that it may be a marker or pathogenic factor for these diseases [55].